Pantuck: We look at the PSA doubling
time, which is the time it takes for the cancer to progress or to get twice as
large or twice as extensive. Thirty percent of the men on the study had some
decrease of their PSA, but 83% had a slowing down of their doubling time.
Narrator: Pantuck has now begun a multi-center, placebo study of the benefits of pomegranate juice.
Pantuck: If it can slow down the progression slow enough, many people may be able to avoid going on to things like hormone therapies go on to avoid things like chemotherapies that have significant impact on quality of life. The best scenario would be that you could ultimately slow it down.
Narrator: For Science Today, I'm Larissa Branin.